Tan IIA enhances chemosensitivity of 5-Fu in colon cancer cells by suppressing nuclear factor-κB43 and overcomes oxaliplatin resistance via inhibiting ERK/Akt signaling36. Here, AKT1 is linked to colonic neoplasm.